Szekeres David Leslie — SEC insider filings
SEC reporting owner CIK 1602459. 20 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2021-01-08 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 4,398 shares, $85,180 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 60.
- Largest priced transaction: sale of 3,571 shares @ $19.66 ($70,219) in HERON THERAPEUTICS, INC. /DE/, filed 2021-01-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Operating Officer | 14 | — | 2 legs · 4,398 sh · $85,180 | 54 |
| GRI Bio, Inc. (GRI) | Director | 6 | — | — | 6 |
Insider filings — Szekeres David Leslie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | GRI Bio, Inc. (GRI) | Grant/award (A): 6,558 (derivative) @ $0 | EDGAR |
| 2025-09-22 | 4 | GRI Bio, Inc. (GRI) | Grant/award (A): 39,897 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | GRI Bio, Inc. (GRI) | Grant/award (A): 10,276 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | GRI Bio, Inc. (GRI) | Grant/award (A): 7,545 (derivative) @ $0 | EDGAR |
| 2025-01-24 | 4 | GRI Bio, Inc. (GRI) | Grant/award (A): 51,937 (derivative) @ $0.69 | EDGAR |
| 2023-08-14 | 4 | GRI BIO, Inc. (GRI) | Grant/award (A): 34,483 (derivative) @ $2.90 | EDGAR |
| 2023-07-17 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $1.31 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2023-04-17 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $2.88 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2023-01-20 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 49,788 (derivative) @ $0 | EDGAR |
| 2023-01-17 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Other (J): 1,654 @ $3.27 · Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $3.17 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2022-10-17 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $3.76 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2022-07-27 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 165,961 (derivative) @ $0 | EDGAR |
| 2022-07-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Other (J): 1,505 @ $3.84 · Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $3.01 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2022-04-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $6.07 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2022-01-14 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Option exercise (M): 4,564 · Tax withholding (F): 2,012 @ $8.30 · Option exercise (M): 1,250 (derivative) @ $0 · Option exercise (M): 4,564 (derivative) @ $0 | EDGAR |
| 2021-10-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Tax withholding (F): 433 @ $10.55 · Option exercise (M): 1,250 (derivative) @ $0 · Grant/award (A): 92,200 (derivative) @ $0 · Grant/award (A): 55,320 (derivative) @ $0 | EDGAR |
| 2021-07-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Other (J): 1,530 @ $13.90 · Option exercise (M): 1,250 · Tax withholding (F): 433 @ $13.48 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2021-04-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Tax withholding (F): 433 @ $16.66 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2021-01-15 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 1,250 · Tax withholding (F): 423 @ $18.16 · Sale (S): 827 @ $18.09 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2021-01-08 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Sale (S): 3,571 @ $19.66 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1602459 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs